A new concept in cancer care: The supportive care program

American Journal of Hospice and Palliative Medicine

Volumn 16, Issue 6, 1999, Pages 713-722

  Esper, Peg ^a   Hampton, Janet N ^a   Finn, John ^b   Smith, David C ^a   Regiani, Sandra ^c   Pienta, Kenneth J ^a  

^a UNIVERSITY OF MICHIGAN COMPREHENSIVE CANCER CENTER   (United States)

^b Hospice of Michigan   (United States)

^c UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; COST BENEFIT ANALYSIS; EVALUATION; HEALTH CARE QUALITY; HOSPICE CARE; HUMAN; MALE; MIDDLE AGED; NONBIOLOGICAL MODEL; ORGANIZATION AND MANAGEMENT; PALLIATIVE THERAPY; PATIENT CARE; PATIENT SELECTION; PILOT STUDY; PROSTATE TUMOR; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; SOCIAL SUPPORT;

AGED; CONTINUITY OF PATIENT CARE; COST-BENEFIT ANALYSIS; HOSPICE CARE; HUMANS; MALE; MIDDLE AGED; MODELS, ORGANIZATIONAL; PALLIATIVE CARE; PATIENT SELECTION; PILOT PROJECTS; PROGRAM EVALUATION; PROSTATIC NEOPLASMS; QUALITY OF LIFE; SOCIAL SUPPORT;

EID: 0033224445     PISSN: 10499091     EISSN: None     Source Type: Journal    
DOI: 10.1177/104990919901600608     Document Type: Article

References (21)

1. Leland JY, Schonwetter RS: Advances in hospice care. Clinics in Geriatric Medicine. 1997; 13 (2): 381-399.
2. Landis SH, Murray T, Bolden S, Wingo PA: Cancer statistics,1998; 48: 6-29.
3. Konety BR, Getzenberg RH: Novel therapies for advanced prostate cancer. Seminars in Urologic Oncology. 1997; 15 (1): 33-42.
4. Tannock IF, Osoba D, Stockle MR, et al.: Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: A Canadian randomized trial with palliative end points. Journal of Clinical Oncology. 1996; 14 (6): 1756-1764.
5. Esper PS, Pienta KJ: Supportive care in the patients with hormone refractory prostate cancer. Seminars in Urologic Oncology. 1997; 15 (1): 56-64.
6. Christakis NA, Escarce JJ: Survival of medical patients after enrollment in hospice programs. New England Journal of Medicine. 1996; 33 (3): 172-178.
7. Bloom BS, Amenta MO: Prospective payment and the Medicare hospice benefit. American Journal of Hospice and Palliative Care. 1993; 10 (2): 32-39.
8. SUPPORT Principal Investigators: A controlled trial to improve care for seriously ill hospitalized patients. JAMA. 1995; 274 (20): 1591-1598.
9. Copp G: Palliative care nursing education-A review of research findings. Journal of Advanced Nursing. 1994; 19 (3): 552-557.
10. Weissman DE, Ambuel B, Norton AJ, et al.: A survey of competencies and concerns in end of life care for physician trainees. Journal of Pain and Symptom Management. 1998; 15 (2): 82-90.
11. Jeffrey D: Education in palliative care: A qualitative evaluation of the present and the needs of general practitioners and community nurses. European Journal of Cancer Care. 1994; 3 (2): 67-74.
12. Ferrell BR, Virani R, Grant M: HOPE. Home care outreach for palliative care education. Cancer Practice. 1998; 6 (2): 79-85.
13. Bascom PB: A hospital-based comfort care team: Consultation for seriously ill and dying patients. American Journal of Hospice and Palliative Care. 1997; 14 (2): 57-60.
14. Lynn J, Wilkinson A, Cohn F, Jones SB: Capitated risk-bearing managed care systems could improve end-of-life care. Journal of the American Geriatrics Society. 1998; 46: 322-330.
15. Emanuel EJ: Cost savings at the end of life. JAMA. 1996; 275 (24): 1907-1914.
16. Lubitz JD, Riley GF: Trend in Medicare payments in the last year of life. New England Journal of Medicine. 1993; 328: 1092-1096.
17. United States Health Care Financing Administration. Medicare Part A Intermediary Manual. DHHS Publication, Part 3, Section 3656.3. Rockville, MD: HCFA, FY 1996.
18. Edelstein EG (ed.): First Database Blue Book. New York: Hearst Corporation, 1995.
19. Cella DF, Tulsky DS, Gray G, et al.: The Functional Assessment of Cancer Therapy (FACT) Scale: Development and validation of the general measure. Journal of Clinical Oncology. 1993; 11: 570-579.
20. Esper P, Mo F, Chodak G, et al.: Measuring quality of life in men with prostate cancer using the Functional Assessment of Cancer Therapy-Prostate instrument. Urology. 1997; 50 (6): 920-928.
21. Smith DC, Esper P, Strawderman M, et al.: A Phase II trial of oral estramustine, oral etoposide, and intravenous paclitaxel in hormone-refractory prostate cancer. Journal of Clinical Oncology. 1999; 17(6): 1664-1671.